Brian Webster, MD
Internal Medicine · Cincinnati, OHNPI 1366567372
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inari Medical, Inc. accounts for 71.2% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for internal medicine clinicians in OH, where the typical reported total is $164.
Across 2 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$29
- E.r. Squibb & Sons, L.L.C.$12
Across 2 payments — averaging $60,965 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$122K
What the payments were for
- Food & beverage$41100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$41 in reported general payments places this provider in the 30th percentile of 4,428 internal medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 14 | $8,278 |
| EliquisApixaban | 15 | $8,242 |
| Levetiracetam | 15 | $862 |
| Levothyroxine Sodium | 24 | $276 |
| Omeprazole | 24 | $243 |
| Atorvastatin Calcium | 30 | $210 |
| Ciprofloxacin Hcl | 33 | $197 |
| Metoprolol Succinate | 27 | $174 |
| ClopidogrelClopidogrel Bisulfate | 17 | $151 |
| Amiodarone Hcl | 11 | $148 |
| Metoprolol Tartrate | 24 | $147 |
| Hydralazine Hcl | 11 | $142 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $110 |
| Torsemide | 11 | $106 |
| Levofloxacin | 24 | $101 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Cincinnati
- Lisa LarkinCincinnati$276K
- Vincent MartinCincinnati$261K
- Kay JohnsonCincinnati$184K
- Jason HatfieldCincinnati$72K
- Rajbir MinhasCincinnati$62K
- Hassan MalikAkron$1.7M
- Cyrus HarrisCleveland$726K
- Nina DeepWesterville$614K
- Necklall KhooblallAustintown$448K
- Daniel WeissMentor$406K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.